Welcome to Our Blog
Let’s Talk Money with Guest Solutions Pharmacy
2022 10 19 Let's Talk Money with Guest Solutions PharmacyGUEST ANGIE FIELDEN
Angie Fielden, LDN Specialist shares her experience of Low Dose Naltrexone
Solutions Pharmacy LDN Specialist & Marketing Director - Angie Fielden shares her experience of Low Dose Naltrexone
Compounders receive a big “V” (victory)
Compounders receive a big “V” (victory): Judge rules in favor of compounders against FDA in a lawsuit over MOU interstate shipments on Tuesday, February 23,...
Lose Dose Naltrexone (LDN) – FREE SEMINAR
Doctors from all over the world have been reporting extremely positive responses for patients with a variety of medical problems.Lose Dose Naltrexone (LDN) - FREE SEMINARQuarterly at 6:00 | LIMITED...
Breast Cancer Awareness Month
Breast Cancer Awareness Month Make sure to schedule your annual mammogram.
Compounding the joy of living one patient at a time
Every day, our compounding pharmacists create tailored medications that make patients healthy, that make patients happy, that make patients whole. Compounding the joy of living one patient at a time."Solutions Pharmacy Compounding you can...
FDA Grants MOU Extension
BREAKING NEWSFDA Grants MOU ExtensionFDA today announced a one-year extension of states to sign the MOU. Following is additional information from FDA.FDA is extending the period for states to decide whether to sign the final standard memorandum of...
CELEBRATION OF LIFE ~ Joshua Talley
IN LOVING MEMORY - JOSH TALLEY (1981-2021) Solutions Pharmacy CO-OWNER – Since 2003 On May 18th, our hearts were broken at the loss of an amazing man, friend, son, and owner of our pharmacy. The Lord called him home at the young age of 39. Josh was...
Update from Solutions Pharmacy Owners
Update from Solutions Pharmacy OwnersDuring COVID-19 Pandemic“For God has not given us a spirit fear,but of power and of love and of a sound mind.”2 Timothy 1:7March 23, 2020If you’re like we are, you are receiving many messages from companies you do...
Updates on appeals to USP Compounding Standards
We received word today that the USP panel has granted our appeal and will remand the BUD date issues in Chapters <795> and <797> to the Compounding Expert Committee for review and engagement with stakeholders. It’s a big win for our APC...